Therapeutic perspectives of Eph-ephrin system modulation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Drug Discovery Today

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.drudis.2013.11.017PMID 24291785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rhesus Monkey Rhadinovirus Uses Eph Family Receptors for Entry into B Cells and Endothelial Cells but Not Fibroblasts

  2013cited by this paper
• Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells.

  2013cited by this paper
• Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor.

  2013cited by this paper
• Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.

  2013cited by this paper
• Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets

  2013cited by this paper
• EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

  2013cited by this paper
• Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.

  2013cited by this paper
• HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.

  2013cited by this paper
• Regulation of apoptosis in HL‐1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid

  2012cited by this paper
• Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor

  2012cited by this paper
• Perturbation of the EphA2-EphrinA1 system in human prostate cancer cells by colonic (poly)phenol catabolites.

  2012cited by this paper
• Targeting Eph receptors with peptides and small molecules: progress and challenges.

  2012cited by this paper
• Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.

  2012cited by this paper
• The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

  2012cited by this paper
• Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

  2012cited by this paper
• Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases.

  2012cited by this paper
• Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection

  2012cited by this paper
• Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth.

  2012cited by this paper
• XL647—A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib

  2012cited by this paper
• Ephs and ephrins: emerging therapeutic targets in neuropathology.

  2012cited by this paper
• EphA2 Activation Promotes the Endothelial Cell Inflammatory Response: A Potential Role in Atherosclerosis

  2012cited by this paper
• EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

  2012cited by this paper
• Hsp90 Inhibitors Are Efficacious against Kaposi Sarcoma by Enhancing the Degradation of the Essential Viral Gene LANA, of the Viral Co-Receptor EphA2 as well as Other Client Proteins

  2012cited by this paper
• A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo

  2012cited by this paper
• Eph receptors at synapses: implications in neurodegenerative diseases.

  2012cited by this paper
• Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells

  2012cited by this paper
• The Eph/Ephrin family in cancer metastasis: communication at the service of invasion

  2012cited by this paper
• Ephrin-A1-Mediated Dopaminergic Neurogenesis and Angiogenesis in a Rat Model of Parkinson's Disease

  2012cited by this paper
• The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus

  2012cited by this paper
• Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

  2011cited by this paper
• A novel vaccine containing EphA2 epitope and LIGHT plasmid induces robust cellular immunity against glioma U251 cells.

  2011cited by this paper
• In Vivo Small-Animal PET/CT of EphB4 Receptors Using 64Cu-Labeled Peptide

  2011cited by this paper
• Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations

  2011cited by this paper
• Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation

  2011cited by this paper
• PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity

  2011cited by this paper
• Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.

  2011cited by this paper
• A Disalicylic Acid‐Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors

  2011cited by this paper
• Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.

  2011cited by this paper
• EphA4 preserves postnatal and adult neural stem cells in an undifferentiated state in vivo

  2011cited by this paper
• A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge

  2011cited by this paper
• Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system.

  2011cited by this paper
• Intramyocardial administration of chimeric ephrinA1‐Fc promotes tissue salvage following myocardial infarction in mice

  2011cited by this paper
• Eph/Ephrin-Mediated Interactions in the Thymus

  2011cited by this paper
• Ephrins Negatively Regulate Cell Proliferation in the Epidermis and Hair Follicle

  2010cited by this paper
• Eph receptors and ephrins in cancer: bidirectional signalling and beyond

  2010cited by this paper
• The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

  2010cited by this paper
• Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer

  2010cited by this paper
• EphB signaling controls lineage plasticity of adult neural stem cell niche cells.

  2010cited by this paper
• EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting.

  2010cited by this paper
• Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.

  2010cited by this paper
• Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

  2010cited by this paper
• Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

  2010cited by this paper
• A Novel Mouse Model for Evaluation and Prediction of HLA-A2-restricted CEA Cancer Vaccine Responses

  2009cited by this paper
• A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection

  2009cited by this paper
• Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.

  2009cited by this paper
• Early Changes in Hippocampal Eph Receptors Precede the Onset of Memory Decline in Mouse Models of Alzheimer's Disease

  2009cited by this paper
• Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).

  2009cited by this paper
• EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia.

  2009cited by this paper
• Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors.

  2009cited by this paper
• Eph-ephrin bidirectional signaling in physiology and disease.

  2008cited by this paper
• Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes

  2008cited by this paper
• Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis.

  2008cited by this paper
• Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors*

  2008cited by this paper
• Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

  2007cited by this paper
• Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors

  2007cited by this paper
• Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

  2007cited by this paper
• Regeneration‐enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord

  2007cited by this paper
• Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus

  2006cited by this paper
• EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus

  2005cited by this paper
• Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.

  2005cited by this paper
• Ephrin A Receptors and Ligands in Lesions and Normal‐Appearing White Matter in Multiple Sclerosis

  2005cited by this paper
• PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature.

  2005cited by this paper
• Lymphangiogenesis in development and human disease

  2005cited by this paper
• Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling

  2004cited by this paper
• Contact‐dependent signaling during the late events of platelet activation

  2003cited by this paper
• Eph signaling: a structural view.

  2003cited by this paper
• Differential EphA2 epitope display on normal versus malignant cells.

  2003cited by this paper
• Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

  2002cited by this paper
• Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation

  2002cited by this paper
• Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

  1999cited by this paper
• Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.

  1999cited by this paper
• Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

  1995cited by this paper

• Engineered Recombinant EGFP-Azurin Theranostic Nanosystem for Targeted Therapy of Prostate Cancer.

  2023cites this paper
• Post-COVID neurocognitive disorders

  2023cites this paper
• Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

  2023cites this paper
• Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases

  2022cites this paper
• The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies

  2022cites this paper
• The EphB6 Receptor: Kinase-Dead but Very Much Alive

  2021cites this paper
• From genetic data and structures to drug development: New approaches to target Eph receptors

  2021cites this paper
• The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases

  2021cites this paper
• Eph Receptors and Ephrins in Retinal Diseases

  2021cites this paper
• Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications

  2020cites this paper
• Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.

  2020cites this paper
• Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions

  2020cites this paper
• The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts

  2020cites this paper
• Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival

  2020cites this paper
• The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis

  2020cites this paper
• Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin‐resistant mice

  2019cites this paper
• Essential roles of EphrinB2 in mammalian heart: from development to diseases

  2019influential citation
• Regulation of A375 melanoma cell adhesion and migration by EphB4 and EphrinB2 – insights from co-culture experiments

  2019cites this paper
• Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction

  2018cites this paper
• Theoretical Model of EphA2-Ephrin A1 Inhibition

  2018cites this paper
• Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein-Protein Interaction Inhibitors Targeting the EphA2 Receptor.

  2017cites this paper
• Identification and characterization of Nanobodies targeting the EphA4 receptor

  2017cites this paper
• Targeting Eph/ephrin system in cancer therapy.

  2017cites this paper
• Identification and characterization of Nanobodies targeting the EphA 4 receptor

  2017cites this paper
• Eph RECEPTORS AS A TARGET TO DEVELOP NOVEL THERAPIES TO CONTROL NEURODEGENERATION AND NEUROPATHIC DISEASES

  2017cites this paper
• Expression and Purification of EPHA2 Tyrosine Kinase Domain for Crystallographic and NMR Studies

  2016cites this paper
• Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

  2016cites this paper
• Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis.

  2016cites this paper
• Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability.

  2016cites this paper
• The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?

  2016cites this paper
• D 5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph e ephrin system

  2015cites this paper
• Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists

  2015cites this paper
• Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.

  2015cites this paper
• Editorial: Small Molecules and Peptides Targeting the Eph-Ephrin System.

  2015cites this paper
• The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells.

  2015cites this paper
• Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors.

  2015cites this paper
• Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.

  2015cites this paper
• Eph receptors and ephrins: therapeutic opportunities.

  2015cites this paper
• Evaluation of novel fluorescence probes for conjugation purposes using the traceless Staudinger Ligation

  2015cites this paper
• Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases.

  2015cites this paper
• Design, Synthesis and Bioevaluation of an EphA2 Receptor‐Based Targeted Delivery System

  2014cites this paper
• A Mathematical Model for Eph/Ephrin-Directed Segregation of Intermingled Cells

  2014cites this paper
• Combining Ligand- and Structure-Based Approaches for the Discovery of New Inhibitors of the EPHA2-ephrin-A1 Interaction

  2014cites this paper
• Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2.

  2014cites this paper
• Development and Structural Analysis of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor

  2014cites this paper
• UniPR129 is a competitive small molecule Eph‐ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations

  2014cites this paper
• EphA3 biology and cancer

  2014cites this paper